Psoriasis looks, feels, and gets treated differently depending on skin tone, and those differences have real consequences. On darker skin, the hallmark redness that doctors are trained to spot often doesn’t appear red at all, which can delay diagnosis and leave people dealing with more severe disease before they get help. Beyond appearance, people of color face distinct challenges with pigment changes after flares, treatment access, and scalp care that deserve specific attention.
What Psoriasis Looks Like on Darker Skin
The classic textbook image of psoriasis is a bright red, scaly plaque on white skin. On darker skin tones, that inflammation shows up as purple, lilac, or more commonly gray. Black patients with psoriasis typically develop thicker plaques with grayish, purple-toned scales compared to the pink-and-silver presentation in white patients. The surrounding skin may also look darker or lighter than normal, adding another layer of visual complexity that doesn’t match what most medical training materials show.
This color difference matters because erythema (redness caused by inflammation) is one of the primary ways doctors assess psoriasis severity. When redness is harder to see, the disease can appear milder than it actually is. Scoring tools used to measure how bad psoriasis is were largely developed using lighter skin, so they can systematically underestimate severity in people with deeper skin tones.
Why Diagnosis Takes Longer
Because psoriasis on darker skin doesn’t always look like the textbook version, it gets confused with other conditions more often. On heavily pigmented skin, psoriasis can closely resemble lichen planus (especially the thickened variety), discoid lupus, and sarcoidosis. All of these cause scaly, raised patches that overlap in appearance with psoriasis when the telltale redness is absent. In some cases, a skin biopsy is the only way to confirm the diagnosis.
This diagnostic difficulty isn’t just an inconvenience. Delayed diagnosis means delayed treatment, and psoriasis that goes untreated tends to worsen over time. It also increases the risk of developing psoriatic arthritis, which affects the joints and can cause permanent damage if not caught early.
The Pigment Changes That Linger
For many people of color, the psoriasis plaques themselves are only half the problem. After a flare clears, the skin often leaves behind dark patches (post-inflammatory hyperpigmentation) or lighter patches (post-inflammatory hypopigmentation) that can persist for months or even years. These pigment changes happen because inflammation disrupts how melanin-producing cells function, either ramping up production, slowing it down, or blocking the transfer of pigment to surrounding skin cells.
These marks can be just as distressing as the active disease, sometimes more so. They’re visible long after the plaques are gone, and they can affect how people feel about their appearance in ways that standard psoriasis severity scores don’t capture. In darker skin tones, the contrast between affected and unaffected areas is more pronounced, making even mild flares cosmetically significant. Physical irritation or friction on the skin can also trigger new psoriasis lesions through what’s called the Koebner phenomenon, which then creates more pigment changes as those new spots heal.
Prevalence Across Racial Groups
Psoriasis affects all racial and ethnic groups, but not at equal rates. A nationally representative U.S. study published in JAMA Dermatology found that 3.6% of non-Hispanic white adults have psoriasis, compared to 1.9% of Hispanic adults and 1.5% of non-Hispanic Black adults. That means white Americans are roughly twice as likely to have the condition.
Lower prevalence doesn’t mean lower impact, though. The genetic underpinnings of psoriasis vary by ethnicity. One of the strongest genetic risk factors, an immune gene called HLA-Cw6, is more common in people of European descent than in Asian or African populations. Other genetic variants associated with inflammatory pathways show different frequencies across ethnic groups, which may influence not just who gets psoriasis but how they respond to certain treatments.
Greater Impact on Quality of Life
Despite lower prevalence rates, Black patients report significantly worse quality of life from their psoriasis. On a standard dermatology quality-of-life scale, Black patients averaged a score of 8.3, compared to 5.6 for white patients. That’s not a small gap. Black, Asian, and Hispanic patients were all significantly more likely than white patients to report that psoriasis meaningfully affected their daily lives.
Several factors drive this disparity. The lingering pigment changes described above contribute to greater cosmetic burden. Diagnostic delays mean patients live with uncontrolled disease longer. And as the next section covers, access to the most effective treatments isn’t equal.
Gaps in Treatment Access
Biologic therapies are among the most effective treatments for moderate-to-severe psoriasis, but Black patients in the U.S. are significantly less likely to receive them. Among Medicare recipients, Black beneficiaries with moderate-to-severe psoriasis were 70% less likely to be prescribed biologics than white beneficiaries, even after accounting for differences in income, other health conditions, and insurance plan type. Clinic-based studies have found similar patterns.
The reasons are complex. Underestimation of disease severity on darker skin plays a role, since patients whose psoriasis appears “milder” on clinical scoring tools may not meet the thresholds that trigger a biologic prescription. Systemic factors like insurance coverage, access to dermatologists, and implicit bias in clinical decision-making all contribute as well.
Scalp Psoriasis and Textured Hair
Scalp psoriasis deserves its own discussion because standard treatment advice often conflicts with the hair care practices of Black women and others with tightly coiled or textured hair. Most prescription psoriasis shampoos are designed to be used daily, but washing textured hair that frequently strips moisture and causes breakage. Women of African descent typically wash their hair once a week to once every other week, and effective treatment needs to work within that routine rather than against it.
Dermatologists experienced with textured hair recommend using prescription shampoo once weekly, potentially increasing to twice weekly for more severe cases. On non-wash days, oil-based topical treatments can be applied to the scalp overnight before the next wash. The vehicle (the substance a medication is mixed into) matters a great deal here: lotions, emollient foams, and oils work much better with coiled hair than gels, solutions, or alcohol-based foams, which can dry out hair and scalp. Asking your dermatologist for a specific formulation that matches your hair texture can make the difference between a treatment you’ll actually use and one that sits in the cabinet.
How Light Therapy Differs for Darker Skin
Narrowband UVB phototherapy is a common treatment for psoriasis, but it requires significant adjustment for people with darker skin. Melanin absorbs UV light, so deeper skin tones need higher starting doses and larger dose increases to achieve the same therapeutic effect. Clinical guidelines call for starting doses nearly three times higher for the darkest skin types compared to the lightest.
There’s an additional challenge: doctors typically gauge whether a phototherapy dose is working by looking for mild redness after treatment. On darker skin, that redness is difficult or impossible to detect visually. Guidelines recommend that doctors rely instead on patient-reported symptoms like burning, stinging, or itching to adjust doses. If you’re undergoing phototherapy, reporting how your skin feels after each session is especially important because your doctor may not be able to see subtle reactions.
Post-treatment hyperpigmentation is another concern. The same UV exposure that clears psoriasis plaques can darken the surrounding skin, leaving behind noticeable color changes. For some patients, this side effect is significant enough to make phototherapy a less appealing option, and it’s worth discussing with your provider before starting treatment.